Partner & Employee Best Access
First time users must log in to Best Access via the Virtual Environment, not via this link.

Blog

Aug 16, 2017

Federal Circuit Clarifies Boundaries of Discovery During Litigation Under the BPCIA

This week, the Federal Circuit issued a much-anticipated precedential decision in Amgen, Inc. v. Hospira, Inc., No. 2016-2179 (Fed. Cir. Aug. 10, 2017), rejecting Amgen's efforts to compel discovery regarding aspects of Hospira's biosimilar application relevant to patents Amgen chose not to identify during the "patent dance" established by the Biologics Price Competition and Innovation […]
back to top